AMLX: Amylyx Pharmaceuticals, Inc. Stock

by  •  • Comments Off on AMLX: Amylyx Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 123.09
Enterprise Value ($M) -47.11
Book Value ($M) 433.43
Book Value / Share 6.37
Price / Book 0.28
NCAV ($M) 380.64
NCAV / Share 5.60
Price / NCAV 0.32

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.14

Liquidity (mrq)
Quick Ratio 5.20
Current Ratio 5.66

Balance Sheet (mrq) ($M)
Current Assets 464.67
Assets 517.45
Liabilities 84.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 380.79
Operating Income 38.80
Net Income 49.27
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 11.92
Cash from Investing 92.05
Cash from Financing 3.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-11 13G Panacea Innovation Ltd 6.20
02-14 13G/A Point72 Asset Management, L.P. 4.70 -7.73
02-14 13G/A Perceptive Advisors Llc 2.80 -69.30
02-14 13G/A Viking Global Investors Lp 4.40 -36.08
02-13 13G/A Vanguard Group Inc 7.81 21.04
01-29 13G BlackRock Inc. 5.90
10-04 13D/A Morningside Venture Investments Ltd 3.43 -49.92
06-09 13G Goldman Sachs Group Inc 5.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 341,220 1,629,862 20.94
2024-04-30 368,693 1,646,014 22.40
2024-04-29 414,846 1,832,860 22.63
2024-04-26 1,052,003 880,525 119.47

(click for more detail)

Similar Companies
ALVR – AlloVir, Inc. ALXO – ALX Oncology Holdings Inc.
AMGN – Amgen Inc. AMPH – Amphastar Pharmaceuticals, Inc.
AMRX – Amneal Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io